NCT01546623View on ClinicalTrials.gov

A Phase 3 Comparative Study of TAP-144-SR(6M) in Prostate Cancer Patients Previously Treated With Hormonal Therapy

PHASE3CompletedINTERVENTIONAL

Enrollment

160

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions

Prostate Cancer

Interventions

DRUG

TAP-144-SR(6M)

DRUG

TAP-144-SR(3M)

Trial Locations (16)

Unknown

Nagoya

Chiba

Fukuoka

Maebashi

Sapporo

Kanazawa

Yokohama

Sendai

Nigata-shi

Osaka

Suita-shi

Ageo-shi

Kita-adachi-gun

Shizuoka

Itabashi-ku

Shinjuku-ku

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Takeda

INDUSTRY

NCT01546623 - A Phase 3 Comparative Study of TAP-144-SR(6M) in Prostate Cancer Patients Previously Treated With Hormonal Therapy | Biotech Hunter | Biotech Hunter